Countries: Canada ▼

Products

Our portfolio of innovative therapies is designed to meet the unique needs of several underserved patient populations.

 

Carbaglu® (carglumic acid dispersible tablets)

  Product Monograph  Consumer Information

Cosmegen® (dactinomycin for injection)

  Product Monograph  Consumer Information

Cystadane® (betaine anhydrous powder for oral solution)

  Product Monograph  Consumer Information
Cystadrops® (cysteamine ophthalmic solution)  Product Monograph  Consumer Information
Panhematin® (hemin for injection)  Product Monograph  Consumer Information
Signifor® LAR (pasireotide for injectable suspension)  Product Monograph  Consumer Information
Signifor® (pasireotide injection)  Product Monograph  Consumer Information
Ledaga™ (chlormethine gel)  Product Monograph  Consumer Information
SYLVANT® (siltuximab for injection)  Product Monograph  Consumer Information

For Medical Information Requests:

1-647-361-5638 (M-F 8 AM-6 PM CT)
1-888-926-3073 (M-F 8 AM-6 PM CT) Toll-Free
medinfocanada@recordatirarediseases.com

Adverse Event Reporting:

1-905-827-1300 (M-F 8:30 AM-5 PM ET)
1-877-827-1306 (M-F 8:30 AM-5 PM ET) Toll-Free
RRDpharmacovigilance@recordati.com

Adverse events can be reported directly to Health Canada. For information on how to report to Health Canada, please visit the Adverse Reaction and Medical Device Problem Reporting page on Health Canada’s website.

Support & Resources

Our top priority is meeting the needs of the rare disease community.
Learn more

Contact us

Contact Recordati Rare Diseases Canada.
Learn more